In the first public European viewing of EKF’s STAT-Site WB for dual analyte measurement from whole blood in seconds, EKF Diagnostics will showcase the β-ketone and glucose handheld analyzer in-person at Medica 2021.
In Medica’s Hall 3, EKF will provide expert point of care diagnostics knowledge and advice. It will also demonstrate the globally successful PrimeStore MTM novel viral transport media alongside the COVID-SeroKlir SARS-CoV-2 IgG antibody IVD kit, as well as showcase further new product innovations relating to the future control of COVID-19.
One of the world’s largest medical trade fairs, Medica will return to Düsseldorf on 15-18th November 2021 to highlight the best new and upcoming technologies in various sectors relating to clinical healthcare. To ensure the safety of visitors, there will be a plethora of COVID-19 safety measures in place, including proof of vaccination/recovery/negative test, ventilation, and sanitization points.
As the first live exhibition attended by EKF Diagnostics in mainland Europe in two years, it will be a perfect opportunity to display the newly released STAT-Site® WB. The dual-compound analyzer allows for easy and quick (5-10 seconds respectively) glucose and β-ketone measurement from whole blood samples. This delivers clear and rapid analysis for diabetic patients displaying ketosis symptoms, thus enabling their rapid treatment.
Other EKF diabetes care products to be exhibited will be the Biosen C-Line Glucose & Lactate analyzer, which measures glucose and lactate in the blood, can measure the analytes individually or together depending on the model. Also, the Quo-Lab and Quo-Test HbA1c analyzers for the point-of-care measurement of glycated hemoglobin supports immediate monitoring and management of diabetes patients.
EKF can help with kitting projects or bespoke fermentation requirements; from raw material sourcing to final packaging EKF can provide the full wing to wing contract manufacturing service.
